The National Healthcare Innovation Centre (NHIC) Singapore was set up in 2014 as an innovation and enterprise office (IEO) for the clinical community of the publicly funded healthcare institutions. It seeks to accelerate healthcare innovation by facilitating the translation of an innovation towards a commercial endpoint, with impact on health and healthcare; and it does so through three key functions- provision of translational funding, mentoring and facilitating deal formations with companies. As a system integrator, it works closely with the clinical and research community, accreditation boards, policy-makers and appropriate end-users, setting up a network that is critical to supporting the research translation pathway. Once hosted as an office under BMS IPO/ A*STAR, it has since been brought back to the MOH family in 2016 as a business unit under the Singapore Clinical Research Institution (SCRI) Pte Ltd.(more details on SCRI below).

For information on NHIC’s funding streams, click here.
For information on NHIC, click here.